{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:11:00Z","timestamp":1789049460239,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11864-022-00976-y","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T12:04:28Z","timestamp":1650456268000},"page":"936-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Constipation in Cancer Patients \u2014 an Update of Clinical Evidence"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-5695","authenticated-orcid":false,"given":"Tomasz","family":"Dzier\u017canowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Mercadante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"976_CR1","doi-asserted-by":"publisher","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scott\u00e9 F, Ripamonti CI. Diagnosis, assessment and management of constipation in advanced cancer: ESMO clinical practice guidelines. Ann Oncol. 2018;29(Supplement_4):iv111\u201325. https:\/\/doi.org\/10.1093\/annonc\/mdy148 The contemporary clinical practice guidelines on constipation in oncology.","DOI":"10.1093\/annonc\/mdy148"},{"key":"976_CR2","doi-asserted-by":"publisher","unstructured":"Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer. 2020. https:\/\/doi.org\/10.1007\/s00520-019-05016-4 The up-to-date clinical practice guidelines on constipation in cancer patients structured according to PICO and in accordance with AGREE II.","DOI":"10.1007\/s00520-019-05016-4"},{"issue":"1","key":"976_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpainsymman.2013.02.016","volume":"47","author":"A Van Lancker","year":"2014","unstructured":"Van Lancker A, Velghe A, Van Hecke A, Verbrugghe M, Van Den Noortgate N, Grypdonck M, Verhaeghe S, Bekkering G, Beeckman D. Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis. J Pain Symptom Manage. 2014;47(1):90\u2013104. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.016.","journal-title":"J Pain Symptom Manage."},{"issue":"6","key":"976_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jpainsymman.2011.07.015","volume":"43","author":"K Clark","year":"2012","unstructured":"Clark K, Smith JM, Currow DC. The prevalence of bowel problems reported in a palliative care population. J Pain Symptom Manage. 2012;43(6):993\u20131000. https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.07.015.","journal-title":"J Pain Symptom Manage."},{"key":"976_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1188\/13.ONF.E92-E100","volume":"40","author":"SC McMillan","year":"2013","unstructured":"McMillan SC, Tofthagen C, Small B, Karver S, Craig D. Trajectory of medication-induced constipation in patients with cancer. Oncol. Nurs. Forum. 2013;40:3. https:\/\/doi.org\/10.1188\/13.ONF.E92-E100.","journal-title":"Oncol. Nurs. Forum"},{"key":"976_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CLEP.S205957","volume":"11","author":"J Sundb\u00f8ll","year":"2019","unstructured":"Sundb\u00f8ll J, Thygesen SK, Veres K, Liao D, Zhao J, Gregersen H, S\u00f8rensen HT. Risk of cancer in patients with constipation. Clin. Epidemiol. 2019;11:299\u2013310. https:\/\/doi.org\/10.2147\/CLEP.S205957.","journal-title":"Clin. Epidemiol."},{"issue":"5","key":"976_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejim.2011.02.014","volume":"22","author":"B Hess","year":"2011","unstructured":"Hess B, Bernardi M, Klotz H-P. Attitude of Swiss physicians towards opioid-induced constipation: a national survey. Eur J Intern Med. 2011;22(5):527\u201331. https:\/\/doi.org\/10.1016\/j.ejim.2011.02.014.","journal-title":"Eur J Intern Med"},{"key":"976_CR8","doi-asserted-by":"crossref","unstructured":"Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology 2016; 150;6:1393-1407.e5. 10.1053\/j.gastro.2016.02.031.","DOI":"10.1053\/j.gastro.2016.02.031"},{"issue":"6","key":"976_CR9","doi-asserted-by":"publisher","first-page":"E211","DOI":"10.1188\/20.ONF.E211-E224","volume":"47","author":"PK Ginex","year":"2020","unstructured":"Ginex PK, Hanson BJ, LeFebvre KB, Lin Y, Moriarty KA, Maloney C, Vrabel M, Morgan RL. Management of opioid-induced and non-opioid-related constipation in patients with cancer: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47(6):E211\u201324. https:\/\/doi.org\/10.1188\/20.ONF.E211-E224.","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"976_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00520-014-2495-6","volume":"23","author":"T Dzier\u017canowski","year":"2015","unstructured":"Dzier\u017canowski T, Cia\u0142kowska-Rysz A. Behavioral risk factors of constipation in palliative care patients. Support Care Cancer. 2015;23(6):1787\u201393. https:\/\/doi.org\/10.1007\/s00520-014-2495-6.","journal-title":"Support Care Cancer"},{"key":"976_CR11","doi-asserted-by":"crossref","unstructured":"Giron\u00e9s Sarri\u00f3 R, Calsina-Berna A, Gozalvo Garc\u00eda A, Esparza-Mi\u00f1ana JM, Ferrer EF, Group W, Project A, Porta-Sales J, Sarri\u00f3 RG, Calsina-Berna A, Garc\u00eda AG, Esparza-Mi\u00f1ana JM, Ferrer EF, Porta-Sales J. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliat Care 2021; 20;1:1. 10.1186\/s12904-020-00693-z.","DOI":"10.1186\/s12904-020-00693-z"},{"issue":"2","key":"976_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1049909111409389","volume":"29","author":"K Clark","year":"2012","unstructured":"Clark K, Byfieldt N, Dawe M, Currow DC. Treating constipation in palliative care. Am J Hosp Palliat Med. 2012;29(2):122\u20135. https:\/\/doi.org\/10.1177\/1049909111409389.","journal-title":"Am J Hosp Palliat Med"},{"issue":"4","key":"976_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jpainsymman.2012.03.016","volume":"45","author":"K Clark","year":"2013","unstructured":"Clark K, Currow DC. Constipation in palliative care: what do we use as definitions and outcome measures? J Pain Symptom Manage. 2013;45(4):753\u201362. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.03.016.","journal-title":"J Pain Symptom Manage."},{"issue":"1","key":"976_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MCG.0000000000000246","volume":"49","author":"J Gaertner","year":"2015","unstructured":"Gaertner J, Siemens W, Camilleri M, Davies A, Drossman DA, Webster LR, Becker G. Definitions and outcome measures of clinical trials regarding opioid-induced constipation. J Clin Gastroenterol. 2015;49(1):9\u201316. https:\/\/doi.org\/10.1097\/MCG.0000000000000246.","journal-title":"J Clin Gastroenterol"},{"key":"976_CR15","doi-asserted-by":"crossref","unstructured":"Dzier\u017canowski T, Larkin P. Proposed criteria for constipation in palliative care patients. A Multicenter Cohort Study. J Clin Med 2021; 10;1:40. 10.3390\/jcm10010040.","DOI":"10.3390\/jcm10010040"},{"issue":"9","key":"976_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"M van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdm056.","journal-title":"Ann Oncol"},{"key":"976_CR17","volume-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018."},{"issue":"5","key":"976_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00520-007-0386-9","volume":"16","author":"MP Davis","year":"2008","unstructured":"Davis MP. Cancer constipation: are opioids really the culprit? Support. Care Cancer. 2008;16(5):427\u20139. https:\/\/doi.org\/10.1007\/s00520-007-0386-9.","journal-title":"Care Cancer"},{"key":"976_CR19","doi-asserted-by":"publisher","unstructured":"Davies A, Leach C, Butler C, Gregory A, Henshaw S, Minton O, Shorthose K, Batsari KM. Opioid-induced constipation in patients with cancer: a \u201creal-world,\u201d multicentre, observational study of diagnostic criteria and clinical features. Pain. 2021;162(1):309\u201318. https:\/\/doi.org\/10.1097\/j.pain.0000000000002024 The study validates Rome IV criteria for OIC in cancer patients.","DOI":"10.1097\/j.pain.0000000000002024"},{"issue":"2","key":"976_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3344\/kjp.2019.32.2.69","volume":"32","author":"K Lang-Illievich","year":"2019","unstructured":"Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain. 2019;32(2):69\u201378. https:\/\/doi.org\/10.3344\/kjp.2019.32.2.69.","journal-title":"Korean J Pain"},{"issue":"2","key":"976_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/01.SMJ.0000109215.54052.D8","volume":"97","author":"PS Staats","year":"2004","unstructured":"Staats PS, Markowitz J, Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J. 2004;97(2):129\u201334. https:\/\/doi.org\/10.1097\/01.SMJ.0000109215.54052.D8.","journal-title":"South Med J"},{"key":"976_CR22","doi-asserted-by":"publisher","unstructured":"Ueberall MA, Mueller-Schwefe G. Opioid-induced constipation - a frequent and distressing side effect in daily practice affecting oral and transdermal opioid applications. Eur J Pain. 2006;10(S1):S172\u20132. https:\/\/doi.org\/10.1016\/S1090-3801(06)60659-9.","DOI":"10.1016\/S1090-3801(06)60659-9"},{"key":"976_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/14651858.CD011108.pub3","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li Y, Ma J, Lu G, Dou Z, Knaggs R, Xia J, Zhao S, Dong S, Yang L. Hydromorphone for cancer pain. Cochrane Database Syst Rev. 2021;2021:8. https:\/\/doi.org\/10.1002\/14651858.CD011108.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"976_CR24","doi-asserted-by":"publisher","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O\u2019Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur. Gastroenterol. J. 2019;7(1):7\u201320. https:\/\/doi.org\/10.1177\/2050640618818305 An up-to-date synthesis of pathophysiology and pragmatic algorithm of OIC management.","DOI":"10.1177\/2050640618818305"},{"key":"976_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/164_2016_116","volume":"239","author":"JJ Galligan","year":"2017","unstructured":"Galligan JJ, Sternini C. Insights into the role of opioid receptors in the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol NIH Public Access. 2017;239:363\u201378. https:\/\/doi.org\/10.1007\/164_2016_116.","journal-title":"Handb Exp Pharmacol NIH Public Access"},{"key":"976_CR26","doi-asserted-by":"publisher","unstructured":"Argoff CE. Opioid-induced Constipation. Clin J Pain. 2020;36(9):716\u201322. https:\/\/doi.org\/10.1097\/AJP.0000000000000852 A review of quality of life, patient burden, and the impact of PAMORA.","DOI":"10.1097\/AJP.0000000000000852"},{"issue":"2","key":"976_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00520-018-4366-z","volume":"27","author":"PG Fine","year":"2019","unstructured":"Fine PG, Chen Y-W, Wittbrodt E, Datto C. Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy. Support Care Cancer. 2019;27(2):687\u201396. https:\/\/doi.org\/10.1007\/s00520-018-4366-z.","journal-title":"Support Care Cancer"},{"key":"976_CR28","doi-asserted-by":"crossref","unstructured":"Crawford GB, Dzier\u017canowski T, Hauser K, Larkin P, Luque-Blanco AI, Murphy I, Puchalski CM, Ripamonti CI. Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines. ESMO Open 2021; 6;4:100225. 10.1016\/j.esmoop.2021.100225.","DOI":"10.1016\/j.esmoop.2021.100225"},{"key":"976_CR29","doi-asserted-by":"crossref","unstructured":"Yang P, Wang Y, Xiao Y, Ma Q, Ma R, Mi J, Hui J. Acupuncture for opioid-induced constipation. Medicine (Baltimore). 2020; 99;49:e23352. 10.1097\/MD.0000000000023352.","DOI":"10.1097\/MD.0000000000023352"},{"key":"976_CR30","doi-asserted-by":"crossref","unstructured":"Dai Q, Yan H, Wu X, Liu Y, Huang F, Dong X. Effectiveness and safety of adjunctive traditional Chinese medicine therapy for constipation after cancer chemotherapy. Medicine (Baltimore). 2020; 99;34:e21770. 10.1097\/MD.0000000000021770.","DOI":"10.1097\/MD.0000000000021770"},{"key":"976_CR31","doi-asserted-by":"crossref","unstructured":"McClurg D, Booth L, Herrero-Fresneda I. Safety and efficacy of intermittent colonic exoperistalsis device to treat chronic constipation: a prospective multicentric clinical trial. Clin. Transl. Gastroenterol. 2020; 11;12:e00267. 10.14309\/ctg.0000000000000267.","DOI":"10.14309\/ctg.0000000000000267"},{"issue":"5","key":"976_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/AJP.0b013e318237d626","volume":"28","author":"M Ishihara","year":"2012","unstructured":"Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y. A Multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin J Pain. 2012;28(5):373\u201381. https:\/\/doi.org\/10.1097\/AJP.0b013e318237d626.","journal-title":"Clin J Pain"},{"issue":"2","key":"976_CR33","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58\u201368. https:\/\/doi.org\/10.1016\/S1470-2045(12)70040-2.","journal-title":"Lancet Oncol"},{"key":"976_CR34","doi-asserted-by":"crossref","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CII. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann. Oncol. 2018; 29;Supplement_4:iv166\u2013iv191. 10.1093\/annonc\/mdy152.","DOI":"10.1093\/annonc\/mdy152"},{"issue":"4","key":"976_CR35","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00520-019-04944-5","volume":"28","author":"P Hawley","year":"2020","unstructured":"Hawley P, MacKenzie H, Gobbo M. PEG vs. sennosides for opioid-induced constipation in cancer care. Support Care Cancer. 2020;28(4):1775\u201382. https:\/\/doi.org\/10.1007\/s00520-019-04944-5.","journal-title":"Support Care Cancer"},{"key":"976_CR36","doi-asserted-by":"publisher","unstructured":"Rekatsina M, Paladini A, Drewes AM, Ayob F, Viswanath O, Urits I, Corli O, Pergolizzi J Jr, Varrassi G. Efficacy and safety of peripherally acting \u03bc-opioid receptor antagonist (PAMORAs) for the management of patients with opioid-induced constipation: a systematic review. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.16201 A recent up-to-date systematic review of PAMORA.","DOI":"10.7759\/cureus.16201"},{"key":"976_CR37","doi-asserted-by":"publisher","unstructured":"Hanson B, Siddique SM, Scarlett Y, Sultan S. American Gastroenterological Association Institute technical review on the medical management of opioid-induced constipation. Gastroenterology. 2019;156(1):229. https:\/\/doi.org\/10.1053\/J.GASTRO.2018.08.018 A relevant review of evidence on pharmacological interventions in OIC.","DOI":"10.1053\/J.GASTRO.2018.08.018"},{"key":"976_CR38","doi-asserted-by":"publisher","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S. American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019;156(1):218\u201326. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.016 Contemporary clinical practice guidelines on the OIC treatment.","DOI":"10.1053\/j.gastro.2018.07.016"},{"key":"976_CR39","doi-asserted-by":"publisher","unstructured":"Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Aliment Pharmacol Ther. 2020;52(1):37\u201353. https:\/\/doi.org\/10.1111\/apt.15791 A recent well structured meta-analysis of OIC treatment options.","DOI":"10.1111\/apt.15791"},{"issue":"3","key":"976_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/gutjnl-2018-316001","volume":"68","author":"P Luthra","year":"2019","unstructured":"Luthra P, Burr NE, Brenner DM, Ford AC. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis. Gut. 2019;68(3):434\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2018-316001.","journal-title":"Gut"},{"key":"976_CR41","doi-asserted-by":"publisher","unstructured":"Nishie K, Yamamoto S, Yamaga T, Horigome N, Hanaoka M. Peripherally acting \u03bc-opioid antagonist for the treatment of opioid-induced constipation: systematic review and meta-analysis. J Gastroenterol Hepatol. 2019;34(5):818\u201329. https:\/\/doi.org\/10.1111\/jgh.14586 A thorough systematic review and meta-analysis of PAMORA.","DOI":"10.1111\/jgh.14586"},{"key":"976_CR42","doi-asserted-by":"publisher","unstructured":"Chedid V, Camilleri M. Assessing the efficacy of peripherally acting mu-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation. Gut. 2019;68(6):1133\u20134. https:\/\/doi.org\/10.1136\/gutjnl-2018-316824 A critical letter on the mechanistic approach to systematic reviews and meta-analyses with essential guides for future reviews.","DOI":"10.1136\/gutjnl-2018-316824"},{"issue":"7","key":"976_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jpm.2014.0362","volume":"18","author":"J Bull","year":"2015","unstructured":"Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension. J Palliat Med. 2015;18(7):593\u2013600. https:\/\/doi.org\/10.1089\/jpm.2014.0362.","journal-title":"J Palliat Med"},{"issue":"22","key":"976_CR44","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","volume":"358","author":"J Thomas","year":"2008","unstructured":"Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358(22):2332\u201343. https:\/\/doi.org\/10.1056\/NEJMoa0707377.","journal-title":"N Engl J Med"},{"key":"976_CR45","first-page":"39","volume":"7","author":"N Slatkin","year":"2009","unstructured":"Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol. 2009;7:39\u201346.","journal-title":"J Support Oncol"},{"issue":"2","key":"976_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2217\/pmt-2019-0045","volume":"10","author":"BH Chamberlain","year":"2020","unstructured":"Chamberlain BH, Rhiner M, Slatkin NE, Stambler N, Israel RJ. Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer. Pain Manag. 2020;10(2):73\u201384. https:\/\/doi.org\/10.2217\/pmt-2019-0045.","journal-title":"Pain Manag."},{"issue":"1","key":"976_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40122-021-00237-0","volume":"10","author":"Y-Y Zhang","year":"2021","unstructured":"Zhang Y-Y, Zhou R, Gu W-J. Efficacy and safety of methylnaltrexone for the treatment of opioid-induced constipation: a meta-analysis of randomized controlled trials. Pain Ther. 2021;10(1):165\u201379. https:\/\/doi.org\/10.1007\/s40122-021-00237-0.","journal-title":"Pain Ther."},{"issue":"6","key":"976_CR48","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/papr.12535","volume":"17","author":"R Rauck","year":"2017","unstructured":"Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ. Randomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer pain. Pain Pract. 2017;17(6):820\u20138. https:\/\/doi.org\/10.1111\/papr.12535.","journal-title":"Pain Pract."},{"key":"976_CR49","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.2147\/JPR.S160625","volume":"11","author":"LR Webster","year":"2018","unstructured":"Webster LR, Israel RJ. Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone. J Pain Res. 2018;11:2509\u201316. https:\/\/doi.org\/10.2147\/JPR.S160625.","journal-title":"J Pain Res"},{"issue":"4","key":"976_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00000542-199710000-00008","volume":"87","author":"DB Murphy","year":"1997","unstructured":"Murphy DB, Sutton JA, Prescott LF, Murphy MB. Opioid-induced Delay in Gastric Emptying. Anesthesiology. 1997;87(4):765\u201370. https:\/\/doi.org\/10.1097\/00000542-199710000-00008.","journal-title":"Anesthesiology"},{"key":"976_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/JPR.S220859","volume":"13","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J. Peripheral opioid receptor antagonists for opioid-induced constipation: a primer on pharmacokinetic variabilities with a focus on drug interactions. J Pain Res. 2020;13:447\u201356. https:\/\/doi.org\/10.2147\/JPR.S220859.","journal-title":"J Pain Res"},{"issue":"8","key":"976_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14656566.2020.1735354","volume":"21","author":"M Daniali","year":"2020","unstructured":"Daniali M, Nikfar S, Abdollahi M. Evaluating naloxegol for the treatment of opioid-induced constipation. Expert Opin Pharmacother. 2020;21(8):883\u201391. https:\/\/doi.org\/10.1080\/14656566.2020.1735354.","journal-title":"Expert Opin Pharmacother"},{"key":"976_CR53","unstructured":"Naloxegol (Professional Patient Advice) - Drugs.com. [https:\/\/www.drugs.com\/ppa\/naloxegol.html#uses]."},{"key":"976_CR54","unstructured":"Moventig | European Medicines Agency. [https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/moventig#authorisation-details-section]."},{"key":"976_CR55","doi-asserted-by":"crossref","unstructured":"Davies A, Tack J, Fernandez A, Chambers J, Sanz JL. Naloxegol for patients with cancer pain diagnosed with opioid induced constipation (OIC): NACASY observational study. J. Clin. Oncol. 2020; 38;15_suppl:e19350\u2013e19350. 10.1200\/JCO.2020.38.15_suppl.e19350.","DOI":"10.1200\/JCO.2020.38.15_suppl.e19350"},{"issue":"1","key":"976_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/bmjspcare-2020-002249","volume":"11","author":"M Cobo Dols","year":"2021","unstructured":"Cobo Dols M, Beato Zambrano C, Cabez\u00f3n Guti\u00e9rrez L, et al. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis. BMJ Support Palliat Care. 2021;11(1):25\u201331. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002249.","journal-title":"BMJ Support Palliat Care"},{"key":"976_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00520-021-06299-2","volume":"1","author":"A Lemaire","year":"2021","unstructured":"Lemaire A, Pointreau Y, Narciso B, Piloquet F-X, Braniste V, Sabat\u00e9 J-M. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation. Support Care Cancer. 2021;1:1\u201310. https:\/\/doi.org\/10.1007\/s00520-021-06299-2.","journal-title":"Support Care Cancer"},{"issue":"4","key":"976_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/PAPR.12640","volume":"18","author":"L Webster","year":"2018","unstructured":"Webster L, Diva U, Tummala R, Sostek M. Treatment with naloxegol versus placebo: pain assessment in patients with noncancer pain and opioid-induced constipation. Pain Pract. 2018;18(4):505\u201314. https:\/\/doi.org\/10.1111\/PAPR.12640.","journal-title":"Pain Pract."},{"key":"976_CR59","doi-asserted-by":"crossref","unstructured":"Webster, MD L, Tummala, MD, MBA, MS R, Diva, PhD U, Lappalainen, MD, PhD J. A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation. J. Opioid Manag. 2016; 12;6:405. doi:10.5055\/jom.2016.0360.","DOI":"10.5055\/jom.2016.0360"},{"key":"976_CR60","unstructured":"Naloxegol in cancer opioid-induced constipation - study results - ClinicalTrials.gov. (https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02745353?view=results)."},{"key":"976_CR61","doi-asserted-by":"crossref","unstructured":"Esmadi M, Ahmad D, Hewlett A. Efficacy of naldemedine for the treatment of opioid-induced constipation: a meta-analysis. J. Gastrointest. Liver Dis. 2019; 28;1:41\u201346. 10.15403\/jgld.2014.1121.281.any.","DOI":"10.15403\/jgld.2014.1121.281.any"},{"issue":"34","key":"976_CR62","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","volume":"35","author":"N Katakami","year":"2017","unstructured":"Katakami N, Harada T, Murata T, Shinozaki K, Tsutsumi M, Yokota T, Arai M, Tada Y, Narabayashi M, Boku N. Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer. J Clin Oncol. 2017;35(34):3859\u201366. https:\/\/doi.org\/10.1200\/JCO.2017.73.0853.","journal-title":"J Clin Oncol"},{"issue":"6","key":"976_CR63","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/annonc\/mdy118","volume":"29","author":"N Katakami","year":"2018","unstructured":"Katakami N, Harada T, Murata T, Shinozaki K, Tsutsumi M, Yokota T, Arai M, Tada Y, Narabayashi M, Boku N. Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Ann Oncol. 2018;29(6):1461\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdy118.","journal-title":"Ann Oncol"},{"key":"976_CR64","doi-asserted-by":"crossref","unstructured":"Vickery R, Li Y, Schwertschlag U, Singla N, Webster L, Canafax D. TD-1211 demonstrates a durable increase in bowel movement frequency and return toward normal bowel function in a 5-week Ph2b Opioid-Induced Constipation (OIC) study. J Pain 2013; 14;4:S78. 10.1016\/j.jpain.2013.01.651.","DOI":"10.1016\/j.jpain.2013.01.651"},{"issue":"12","key":"976_CR65","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1021\/acsmedchemlett.9b00406","volume":"10","author":"DD Long","year":"2019","unstructured":"Long DD, Armstrong SR, Beattie DT, Campbell CB, Church TJ, Colson P-J, Dalziel SM, Jacobsen JR, Jiang L, Obedencio GP, Rapta M, Saito D, Stergiades I, Tsuruda PR, Van Dyke PM, Vickery RG. Discovery of axelopran (TD-1211): a peripherally restricted \u03bc-opioid receptor antagonist. ACS Med Chem Lett. 2019;10(12):1641\u20137. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00406.","journal-title":"ACS Med Chem Lett"},{"key":"976_CR66","unstructured":"Alvimopan monograph for professionals - Drugs.com. (https:\/\/www.drugs.com\/monograph\/alvimopan.html)."},{"key":"976_CR67","unstructured":"Optimisation of hydromorphone - naloxone ratio for the treatment of pain. (https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00992576?term=NCT00992576&draw=2&rank=1)."},{"issue":"8","key":"976_CR68","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/pme.12775","volume":"16","author":"M Sanders","year":"2015","unstructured":"Sanders M, Jones S, L\u00f6wenstein O, Jansen J-P, Miles H, Simpson K. New formulation of sustained release naloxone can reverse opioid induced constipation without compromising the desired opioid effects. Pain Med. 2015;16(8):1540\u201350. https:\/\/doi.org\/10.1111\/pme.12775.","journal-title":"Pain Med."},{"key":"976_CR69","doi-asserted-by":"crossref","unstructured":"Davis M, Gamier P. New options in constipation management. Curr Oncol Rep 2015; 17;12:55. 10.1007\/s11912-015-0481-x.","DOI":"10.1007\/s11912-015-0481-x"},{"issue":"10","key":"976_CR70","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","volume":"55","author":"CEJ Sloots","year":"2010","unstructured":"Sloots CEJ, Rykx A, Cools M, Kerstens R, De Pauw M. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. Dig Dis Sci. 2010;55(10):2912\u201321. https:\/\/doi.org\/10.1007\/s10620-010-1229-y.","journal-title":"Dig Dis Sci"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-022-00976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-022-00976-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-022-00976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T16:22:57Z","timestamp":1654618977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-022-00976-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s11864-022-00976-y","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"11 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Tomasz Dzierzanowski has received compensation for service as a consultant from Bausch Health, and has received speaker\u2019s honoraria as well as non-financial support (equipment, materials, etc.) from Molteni Farmaceutici. Sebastiano Mercadante declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}